Anthropic Pushes Claude Into Drug Discovery
Anthropic shared early results from using Claude inside real drug development workflows across six biotech partnerships. The projects span antibody design, trial planning, preclinical lab work, biotech company operations, and Anthropic's own drug programs targeting rare childhood diseases and cancer.
- The partnerships include six medicine builders working across organizations such as BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.
- Anthropic frames drug development as a distributed bottleneck problem covering target discovery, molecule design, manufacturing, regulatory filings, trial design, and trial administration.
- Claude Science connects biology research tools such as PubMed and Jupyter so scientists can move through literature review, analysis, and structure work in a single environment.
